Different medication safety of enteropathogenic Escherichia coli Isolated from kids with the diarrhea in Kashan, Iran

Abstract


Kamshad Nazanin Omidyar, Camilar Ansari, Shohreh Kazemi

Enteropathogenic Escherichia coli (EPEC) is a major cause of diarrhea in infants and children in developing countries. However, recent studies have shown its prevalence in developed countries. The purpose of this study was to evaluate the multi-drug resistant (MDR) of EPEC isolated from children less than five years old with diarrhea hospitalized in Kashan Shahid Beheshti hospital during 2009-10. Stool samples were collected from 313 children less than five years old with diarrhea at Shahid Beheshti Hospital, Kashan, Iran, from November 2009 to May 2010. Specimens were examined by polymerase chain reaction (PCR) test to determine the eae gene for detection of EPEC pathotype. The isolated multi-drug resistance pattern of EPEC was evaluated by disk diffusion agar. The antimicrobial disks used were ampicillin, nalidixic acid, ceftriaxone, ciprofloxacin, cefalexin, ceftazidime, streptomycin and imipenem. Of all 178 E. coli cases 51 (28.6%) EPEC pathotypes were isolated. The prevalence of EPEC was higher in children less than one year old. MDR rate in EPEC was 70.6%.The exact application of antibiogram test is necessary before antibiotic prescription for complete treatment and prevention of diarrhea caused by multi-drug resistant agents

Share this article